Business
Wells Starts Pfizer Overweight, Says Covid Treatments Here to Stay
A woman holds a small bottle labeled “Coronavirus COVID-19 Vaccine” and a medical syringe in front of the Pfizer logo shown in this illustration taken, October 30, 2020.
Dado Ruvic | Reuters
Pfizer According to Wells Fargo, it’s poised to perform better as its Covid treatments stick around and generate massive revenue for the company.